HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients

BACKGROUND: Optimizing HCV genotype 1 therapy in terms of response prediction and tailoring treatment is undoubtedly the cornerstone of treating HIV co-infected patients in clinical practice. Accordingly, our aim was to analyze the predictive value of HCV viral decline for sustained virological resp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rivero-Juarez, Antonio, López-Cortés, Luis F., Camacho, Angela, Torres-Cornejo, Almudena, Gordon, Ana, Ruiz-Valderas, Rosa, Torre-Cisneros, Julian, Pineda, Juan A., Viciana, Pompeyo, Rivero, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063713/
https://ncbi.nlm.nih.gov/pubmed/24945348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0099468
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars